The cross-sectional and longitudinal associations of diabetic retinopathy with cognitive function and brain MRI findings: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial

Christina E Hugenschmidt, James F Lovato, Walter T Ambrosius, R Nick Bryan, Hertzel C Gerstein, Karen R Horowitz, Lenore J Launer, Ronald M Lazar, Anne M Murray, Emily Y Chew, Ronald P Danis, Jeff D Williamson, Michael E Miller, Jingzhong Ding, Christina E Hugenschmidt, James F Lovato, Walter T Ambrosius, R Nick Bryan, Hertzel C Gerstein, Karen R Horowitz, Lenore J Launer, Ronald M Lazar, Anne M Murray, Emily Y Chew, Ronald P Danis, Jeff D Williamson, Michael E Miller, Jingzhong Ding

Abstract

Objective: Longitudinal evidence linking diabetic retinopathy with changes in brain structure and cognition is sparse. We used data from the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial to determine whether diabetic retinopathy at baseline predicted changes in brain structure or cognition 40 months later.

Research design and methods: Participants from the ACCORD-MIND and ACCORD-Eye substudies were included in analyses of cognition (n = 1,862) and MRI-derived brain variables (n = 432). Retinopathy was categorized as none, mild nonproliferative, or moderate/severe. Tests of cognition included the Mini-Mental State Examination (MMSE), Digit Symbol Substitution Test (DSST), Rey Auditory Verbal Learning Test, and Stroop test. Primary brain outcomes were gray matter and abnormal white matter volumes.

Results: Baseline retinopathy was associated with lower gray matter volume (adjusted means of 470, 466, and 461 cm(3) for none, mild, and moderate/severe retinopathy, respectively; P = 0.03). Baseline retinopathy also predicted a greater change in MMSE and DSST scores at 40 months in each retinopathy category (MMSE: -0.20, -0.57, and -0.42, respectively [P = 0.04]; DSST: -1.30, -1.84, and -2.89, respectively [P = 0.01]).

Conclusions: Diabetic retinopathy is associated with future cognitive decline in people with type 2 diabetes. Although diabetic retinopathy is not a perfect proxy for diabetes-related brain and cognitive decline, patients with type 2 diabetes and retinopathy represent a subgroup at higher risk for future cognitive decline.

Trial registration: ClinicalTrials.gov NCT00000620.

© 2014 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered.

Figures

Figure 1
Figure 1
Diagram of subject selection for the current analysis.

References

    1. Brown WR, Thore CR. Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol 2011;37:56–74
    1. Cheung N, Mosley T, Islam A, et al. Retinal microvascular abnormalities and subclinical magnetic resonance imaging brain infarct: a prospective study. Brain 2010;133(Pt 7):1987–1993
    1. Longstreth W, Jr, Larsen EK, Klein R, et al. . Associations between findings on cranial magnetic resonance imaging and retinal photography in the elderly: the Cardiovascular Health Study. Am J Epidemiol 2007;165:78–84
    1. Manschot SM, Biessels GJ, de Valk H, et al. Utrecht Diabetic Encephalopathy Study Group . Metabolic and vascular determinants of impaired cognitive performance and abnormalities on brain magnetic resonance imaging in patients with type 2 diabetes. Diabetologia 2007;50:2388–2397
    1. Manschot SM, Brands AM, van der Grond J, et al. Utrecht Diabetic Encephalopathy Study Group . Brain magnetic resonance imaging correlates of impaired cognition in patients with type 2 diabetes. Diabetes 2006;55:1106–1113
    1. Wong TY, Klein R, Sharrett AR, et al. ARIC Investigators. Atheroslerosis Risk in Communities Study . Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002;288:67–74
    1. Saczynski JS, Siggurdsson S, Jonsson PV, et al. . Glycemic status and brain injury in older individuals: the Age Gene/Environment Susceptibility-Reykjavik Study. Diabetes Care 2009;32:1608–1613
    1. Schmidt R, Launer LJ, Nilsson LG, et al. CASCADE Consortium . Magnetic resonance imaging of the brain in diabetes: the Cardiovascular Determinants of Dementia (CASCADE) Study. Diabetes 2004;53:687–692
    1. Bryan RN, Bilello M, Davatzikos C, et al. . Effect of diabetes on brain structure: the Action to Control Cardiovascular Risk in Diabetes MR imaging baseline data. Radiology 2014;272:210–216
    1. Patton N, Aslam T, Macgillivray T, Pattie A, Deary IJ, Dhillon B. Retinal vascular image analysis as a potential screening tool for cerebrovascular disease: a rationale based on homology between cerebral and retinal microvasculatures. J Anat 2005;206:319–348
    1. Gerstein HC, Ambrosius WT, Danis R, et al. ACCORD Study Group . Diabetic retinopathy, its progression, and incident cardiovascular events in the ACCORD trial. Diabetes Care 2013;36:1266–1271
    1. Mimoun L, Massin P, Steg G. Retinal microvascularisation abnormalities and cardiovascular risk. Arch Cardiovasc Dis 2009;102:449–456
    1. Kwa VI, van der Sande JJ, Stam J, Tijmes N, Vrooland JL, Amsterdam Vascular Medicine Group . Retinal arterial changes correlate with cerebral small-vessel disease. Neurology 2002;59:1536–1540
    1. Qiu C, Cotch MF, Sigurdsson S, et al. . Microvascular lesions in the brain and retina: The Age, Gene/Environment Susceptibility-Reykjavik Study. Ann Neurol 2009;65:569–576
    1. Last D, Alsop DC, Abduljalil AM, et al. . Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity. Diabetes Care 2007;30:1193–1199
    1. Wong TY, Mosley TH, Jr, Klein R, et al. Atherosclerosis Risk in Communities Study . Retinal microvascular changes and MRI signs of cerebral atrophy in healthy, middle-aged people. Neurology 2003;61:806–811
    1. Baker ML, Marino Larsen EK, Kuller LH, et al. . Retinal microvascular signs, cognitive function, and dementia in older persons: the Cardiovascular Health Study. Stroke 2007;38:2041–2047
    1. Wong TY, Klein R, Sharrett AR, et al. . Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke 2002;33:1487–1492
    1. Akisaki T, Sakurai T, Takata T, et al. . Cognitive dysfunction associates with white matter hyperintensities and subcortical atrophy on magnetic resonance imaging of the elderly diabetes mellitus Japanese Elderly Diabetes Intervention Trial (J-EDIT). Diabetes Metab Res Rev 2006;22:376–384
    1. van Harten B, Oosterman J, Muslimovic D, van Loon BJ, Scheltens P, Weinstein HC. Cognitive impairment and MRI correlates in the elderly patients with type 2 diabetes mellitus. Age Ageing 2007;36:164–170
    1. ACCORD Study Group. Buse JB, Bigger JT, Byington RP, et al. . Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol 2007;99(12A):21i–33i
    1. Chew EY, Ambrosius WT, Howard LT, et al. ACCORD Study Group . Rationale, design, and methods of the Action to Control Cardiovascular Risk in Diabetes Eye Study (ACCORD-EYE). Am J Cardiol 2007;99(12A):103i–111i
    1. Launer LJ, Miller ME, Williamson JD, et al. ACCORD MIND investigators . Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol 2011;10:969–977
    1. Atkinson HH, Rosano C, Simonsick EM, et al. Health ABC study . Cognitive function, gait speed decline, and comorbidities: the Health, Aging and Body Composition study. J Gerontol A Biol Sci Med Sci 2007;62:844–850
    1. Chew EY, Ambrosius WT. Update of the ACCORD Eye Study. N Engl J Med 2011;364:188–189
    1. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198
    1. Salthouse TA, Skovronek E. Within-context assessment of age differences in working memory. J Gerontol 1992;47:110–120
    1. Kopelman MD. The Autobiographical Memory Interview (AMI) in organic and psychogenic amnesia. Memory 1994;2:211–235
    1. MacLeod CM. Half a century of research on the Stroop effect: an integrative review. Psychol Bull 1991;109:163–203
    1. Goldszal AF, Davatzikos C, Pham DL, Yan MX, Bryan RN, Resnick SM. An image-processing system for qualitative and quantitative volumetric analysis of brain images. J Comput Assist Tomogr 1998;22:827–837
    1. Lao Z, Shen D, Liu D, et al. . Computer-assisted segmentation of white matter lesions in 3D MR images using support vector machine. Acad Radiol 2008;15:300–313
    1. Ding J, Strachan MW, Reynolds RM, et al. Edinburgh Type 2 Diabetes Study Investigators . Diabetic retinopathy and cognitive decline in older people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes 2010;59:2883–2889
    1. Lesage SR, Mosley TH, Wong TY, et al. . Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study. Neurology 2009;73:862–868
    1. Jacobson AM, Ryan CM, Cleary PA, et al. Diabetes Control and Complications Trial/EDIC Research Group . Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort. Diabetologia 2011;54:245–255
    1. Haan M, Espeland MA, Klein BE, et al. Women’s Health Initiative Memory Study and the Women’s Health Initiative Sight Exam . Cognitive function and retinal and ischemic brain changes: the Women’s Health Initiative. Neurology 2012;78:942–949
    1. Qiu C, Sigurdsson S, Zhang Q, et al. Diabetes, markers of brain pathology and cognitive cognition: the Age, Gene/Environment Susceptibility-Reykjavik Study. Ann Neurol 2013;75:138–146
    1. Kawasaki R, Cheung N, Mosley T, et al. . Retinal microvascular signs and 10-year risk of cerebral atrophy: the Atherosclerosis Risk in Communities (ARIC) study. Stroke 2010;41:1826–1828
    1. Mosley TH, Jr, Knopman DS, Catellier DJ, et al. . Cerebral MRI findings and cognitive functioning: the Atherosclerosis Risk in Communities study. Neurology 2005;64:2056–2062
    1. Crosby-Nwaobi RR, Sivaprasad S, Amiel S, Forbes A. The relationship between diabetic retinopathy and cognitive impairment. Diabetes Care 2013;36:3177–3186
    1. Reijmer YD, van den Berg E, de Bresser J, et al. Utrecht Diabetic Encephalopathy Study Group . Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors. Diabetes Metab Res Rev 2011;27:195–202

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner